全文获取类型
收费全文 | 16385篇 |
免费 | 1992篇 |
国内免费 | 522篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 331篇 |
妇产科学 | 68篇 |
基础医学 | 720篇 |
口腔科学 | 50篇 |
临床医学 | 1494篇 |
内科学 | 2661篇 |
皮肤病学 | 57篇 |
神经病学 | 381篇 |
特种医学 | 194篇 |
外国民族医学 | 1篇 |
外科学 | 957篇 |
综合类 | 3428篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 408篇 |
眼科学 | 4569篇 |
药学 | 1614篇 |
10篇 | |
中国医学 | 1844篇 |
肿瘤学 | 67篇 |
出版年
2024年 | 50篇 |
2023年 | 449篇 |
2022年 | 485篇 |
2021年 | 801篇 |
2020年 | 784篇 |
2019年 | 645篇 |
2018年 | 717篇 |
2017年 | 735篇 |
2016年 | 783篇 |
2015年 | 759篇 |
2014年 | 1150篇 |
2013年 | 1197篇 |
2012年 | 1058篇 |
2011年 | 1145篇 |
2010年 | 876篇 |
2009年 | 749篇 |
2008年 | 807篇 |
2007年 | 781篇 |
2006年 | 646篇 |
2005年 | 606篇 |
2004年 | 486篇 |
2003年 | 394篇 |
2002年 | 347篇 |
2001年 | 318篇 |
2000年 | 239篇 |
1999年 | 214篇 |
1998年 | 170篇 |
1997年 | 159篇 |
1996年 | 113篇 |
1995年 | 126篇 |
1994年 | 104篇 |
1993年 | 89篇 |
1992年 | 84篇 |
1991年 | 69篇 |
1990年 | 68篇 |
1989年 | 68篇 |
1988年 | 51篇 |
1987年 | 52篇 |
1986年 | 50篇 |
1985年 | 77篇 |
1984年 | 65篇 |
1983年 | 39篇 |
1982年 | 73篇 |
1981年 | 42篇 |
1980年 | 38篇 |
1979年 | 22篇 |
1978年 | 22篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的观察分析眼球钝挫伤合并外伤性晶状体脱位患者周边隐匿性视网膜病变的临床特点及预后。 方法本研究纳入2013年1月至2020年1月在柳州市人民医院眼科住院诊断为眼球钝挫伤合并外伤性晶状体脱位,并行23G微创玻璃体切割联合白内障摘除手术的72例(72眼)患者。根据裂隙灯和超声生物显微镜(UBM)检查,将患者分为晶状体不全脱位组和全脱位组,详细记录2组患者的术中周边视网膜病变情况,并分析其临床特征及疗效。 结果眼球钝挫伤合并外伤性晶状体脱位患者中有周边隐匿性视网膜病变的占72.22%,其中晶状体不全脱位组发生率高达80.95%,显著大于晶状体全脱位组的60.00%(P<0.05)。2组患者的周边隐匿性视网膜病变均以隐匿性视网膜裂孔、变性和出血为最常见。所有患者术后视网膜情况稳定,视力预后较好。 结论眼球钝挫伤合并外伤性晶状体脱位患者常出现周边隐匿性视网膜病变,最常见的是视网膜裂孔、出血、变性。23G微创玻璃体切割联合白内障摘除手术是有效治疗手段,具有创伤小、并发症少的优势。 相似文献
3.
4.
5.
6.
7.
Sarah J. Schrauben Haochang Shou Xiaoming Zhang Amanda Hyre Anderson Joseph V. Bonventre Jing Chen Steven Coca Susan L. Furth Jason H. Greenberg Orlando M. Gutierrez Joachim H. Ix James P. Lash Chirag R. Parikh Casey M. Rebholz Venkata Sabbisetti Mark J. Sarnak Michael G. Shlipak Sushrut S. Waikar Paul L. Kimmel Ramachandran S. Vasan Harold I. Feldman Jeffrey R. Schelling 《Journal of the American Society of Nephrology : JASN》2021,32(1):115
8.
Diabetic macular ischaemia (DMI) is traditionally defined and graded based on the angiographic evidence of an enlarged and irregular foveal avascular zone. However, these anatomical changes are not surrogate markers for visual impairment. We postulate that there are vascular phenotypes of DMI based on the relative perfusion deficits of various retinal capillary plexuses and choriocapillaris. This review highlights several mechanistic pathways, including the role of hypoxia and the complex relation between neurons, glia, and microvasculature. The current animal models are reviewed, with shortcomings noted. Therefore, utilising the advancing technology of optical coherence tomography angiography (OCTA) to identify the reversible DMI phenotypes may be the key to successful therapeutic interventions for DMI. However, there is a need to standardise the nomenclature of OCTA perfusion status. Visual acuity is not an ideal endpoint for DMI clinical trials. New trial endpoints that represent disease progression need to be developed before irreversible vision loss in patients with DMI. Natural history studies are required to determine the course of each vascular and neuronal parameter to define the DMI phenotypes. These DMI phenotypes may also partly explain the development and recurrence of diabetic macular oedema. It is also currently unclear where and how DMI fits into the diabetic retinopathy severity scales, further highlighting the need to better define the progression of diabetic retinopathy and DMI based on both multimodal imaging and visual function. Finally, we discuss a complete set of proposed therapeutic pathways for DMI, including cell-based therapies that may provide restorative potential. 相似文献
9.
10.
Age-related eye diseases, including dry eye, glaucoma, age-related macular degeneration, and diabetic retinopathy, represent a major global health issue based on their increasing prevalence and disabling action. Unraveling the molecular mechanisms underlying these diseases will provide novel opportunities to reduce the burden of age-related eye diseases and improve eye health, contributing to sustainable development goals achievement. The impairment of neutrophil extracellular traps formation/degradation processes seems to be one of these mechanisms. These traps formed by a meshwork of DNA and neutrophil cytosolic granule proteins may exacerbate the inflammatory response promoting chronic inflammation, a pivotal cause of age-related diseases. In this review, we describe current findings that suggest the role of neutrophils and their traps in the pathogenesis of the above-mentioned age-related eye diseases. Furthermore, we discuss why these cells and their constituents could be biomarkers and therapeutic targets for dry eye, glaucoma, age-related macular degeneration, and diabetic retinopathy. We also examine the therapeutic potential of some neutrophil function modulators and provide several recommendations for future research in age-related eye diseases. 相似文献